Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Eli Lilly & Co.

NYS: LLY

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Eli Lilly & Co.

Market open

LLY
/zigman2/quotes/200106384/composite

$

294.83

Change

+8.56 +2.99%

Volume

Volume 1.52m

May 20, 2022, 1:48 p.m.

Real time quotes

/zigman2/quotes/200106384/composite

Previous close

$ 286.27

$ 294.83

Change

+8.56 +2.99%

Day low

Day high

$288.92

$298.94

Open
Open: 290.73

52 week low

52 week high

$195.50

$314.00

Open

Market cap

$272.00B

Average volume

2.96M

P/E ratio

43.57

Rev. per Employee

$837,794

EPS

6.74

Dividend

0.98

Div yield

1.33%

Ex dividend date

5/13/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lly

MarketWatch News on LLY

  3. A Biology Revolution Is Coming. Here’s How to Invest.

    10:25 a.m. May 12, 2022

    - Lauren Foster

  6. Eli Lilly shares jump 1.7% premarket

    6:57 a.m. May 11, 2022

    - Ciara Linnane

  7. FDA approves Eli Lilly and Incyte's Olumiant for treatment of certain hospitalized adults with COVID-19

    6:57 a.m. May 11, 2022

    - Ciara Linnane

  10. Pfizer to Buy Biohaven Pharmaceuticals for $11.6 Billion

    10:06 a.m. May 10, 2022

    - Lina Saigol

  13. Eli Lilly stock price target raised to $356 from $315 at Mizuho

    6:15 a.m. May 2, 2022

    - Tomi Kilgore

  14. Alzheimer’s Drugs Face a Crucial Test

    5:26 p.m. April 29, 2022

    - Josh Nathan-Kazis

  15. Eli Lilly stock price target raised to $342 from $292 at Truist

    7:12 a.m. April 29, 2022

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/lly

Other News on LLY

  1. Lilly, Incyte's Olumiant get EMA panel nod for hair loss disorder alopecia areata

    9:56 a.m. Today

    - Seeking Alpha

  2. Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo

    9:25 a.m. Today

    - Zacks.com

  4. This Safe Stock Is Dirt Cheap -- and It's Beating the Market

    8:03 a.m. Today

    - Motley Fool

  5. Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?

    6:20 a.m. Today

    - Zacks.com

  7. Galapagos: Can The Company Turn Around?

    1:18 p.m. May 19, 2022

    - Seeking Alpha

  8. 4 Large Drug Stocks to Watch as the Industry Recovers

    9:32 a.m. May 19, 2022

    - Zacks.com

  9. IXJ: Healthcare Dashboard For May

    9:23 a.m. May 19, 2022

    - Seeking Alpha

  12. The Correction In Biopharmaceutical Stocks Is Likely Over

    12:51 a.m. May 18, 2022

    - Seeking Alpha

  13. ImmunoGen: An Inflection Point In Growth

    4:16 p.m. May 17, 2022

    - Seeking Alpha

  15. Why Eli Lilly Stock Climbed Today

    2:20 p.m. May 16, 2022

    - Motley Fool

  17. Top 5 1st Quarter Trades of Avidity Partners Management LP

    1:00 p.m. May 16, 2022

    - GuruFocus.com

  20. Top 5 1st Quarter Trades of THOMPSON DAVIS & CO., INC.

    9:00 p.m. May 13, 2022

    - GuruFocus.com

  21. Loading more headlines...
/news/pressrelease/company/us/lly

Press Releases on LLY

  1. 3 Health Care Stocks To Watch Right Now

    12:30 p.m. Today

    - StockMarket.com

  6. Top Stock Market News For Today May 17, 2022

    4:43 a.m. May 17, 2022

    - StockMarket.com

  7. Lilly to Participate in UBS Global Healthcare Conference 2022

    2:00 p.m. May 16, 2022

    - PR Newswire - PRF

  13. How To Trade Eli Lilly LLY

    4:41 a.m. May 13, 2022

    - Stock Traders Daily

  15. Heart Failure Treatment Offers Hope to Diabetics

    8:04 a.m. May 11, 2022

    - Financial News Media

  16. Heart Failure Treatment Offers Hope to Diabetics

    8:00 a.m. May 11, 2022

    - PR Newswire - PRF

  19. Mary Lynne Hedley Elected to Lilly Board of Directors

    2:00 p.m. May 6, 2022

    - PR Newswire - PRF

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.